摘要
以射频消融(RFA)为代表的局部消融治疗已成为肝癌的重要治疗手段,在肝癌治疗中得到广泛的应用。其主要适应证为肿瘤单发、直径≤5 cm;或者肿瘤2～3个、最大直径≤3 cm。数个临床研究表明射频治疗小肝癌的效果与手术切除相当,国内外多个肝癌临床治疗指南已经将射频与手术切除一样,并列为小肝癌的根治性治疗方法。临床上RFA常常与手术切除、血管介入、瘤内无水酒精注射术、放射治疗、化疗、靶向药物治疗、免疫生物治疗等方法联合应用,在肝癌多学科综合治疗领域中起着越来越重要的作用。
Radiofrequency ablation（RFA） has been an important treatment for hepatocellular carcinoma（HCC）.The good candidates of RFA are patients with HCC at early stage（solitary≤5 cm in diameter or ≤3 nodules,≤3 cm in diameter）.Several clinical trials have shown that RFA was as effective as resection in the treatment of small HCC.Until now,RFA has been widely used as a radical treatment for small HCC.RFA also plays an important role in multidisciplinary treatment of HCC and usually combines with other therapies such as resection,vascular intervention,intra-tumor ethanol injection,radiotherapy,chemotherapy,targeted drug therapy,biological immune therapy. 更多
出处
《临床肝胆病杂志》
CAS
2011年第4期368-371,共4页
Journal of Clinical Hepatology
关键词
导管消融术
肝肿瘤
catheter ablation； liver neoplasms；
